非贫血性铁缺乏与择期心脏手术后结局的关联(IDOCS):一项前瞻性队列研究
在澳大利亚两家医院开展前瞻性队列研究,纳入480例无贫血的择期心脏手术成人,按术前铁状态分层为铁缺乏组(240例)与铁充足组(240例)。主要终点为术后第30天存活且在家天数,两组中位数分别为22.87天与23.18天,未校正差值-0.18天(95%CI -0.73至0.36;p=0.51),校正差值-0.11天(95%CI -0.66至0.45;p=0.70)。作者认为非贫血性铁缺乏与术后第30天存活且在家天数减少无关。
要点
- 无贫血择期心脏手术患者中,铁缺乏组与铁充足组术后第30天存活且在家天数无显著差异(校正差值-0.11天,95%CI -0.66至0.45;p=0.70)。
- 铁缺乏定义为血清铁蛋白<100 μg/L,或铁蛋白100-300 μg/L且转铁蛋白饱和度<20%或C反应蛋白>5 mg/L。
- 作者认为按所测试定义对无贫血患者常规术前铁缺乏检查可能为低价值医疗。
核心结论
- 在无贫血的择期心脏手术成人中,铁缺乏患者与铁状态正常患者相比,术后第30天存活且在家天数未见减少。
- 作者认为,按本研究所测试的定义,对无贫血择期心脏手术患者常规进行术前铁缺乏检查可能为低价值医疗。
研究设计与样本
- 前瞻性队列研究,在澳大利亚两家医院开展,研究时间为2018年2月21日至2021年5月7日。
- 评估1171例患者资格,691例不符合条件,最终纳入并随访480例无贫血的择期心脏手术成人(年龄≥18岁)。
- 排除标准包括贫血(男性血红蛋白<130 g/L、女性<120 g/L)、合并血红蛋白病、骨髓病理、血色病或需透析的终末期肾衰竭。
- 参与者按术前检测结果分为铁缺乏组240例(50%)与铁充足组240例(50%);女性95例(20%)、男性385例(80%),白人453例(94%)。
- 主要终点为术后第30天存活且在家天数,主要分析纳入有主要终点数据的全部患者,并校正EuroSCORE-II风险评分和体表面积。
主要发现
- 主要终点完整数据共479例(铁缺乏组240例、铁充足组239例)。
- 铁缺乏组术后第30天存活且在家天数中位数22.87天(IQR 20.65至24.06),铁充足组中位数23.18天(IQR 20.69至24.70)。
- 两组中位数未校正差值为-0.18天(95%CI -0.73至0.36;p=0.51),校正差值为-0.11天(95%CI -0.66至0.45;p=0.70),均未达统计学显著。
关键数值与推荐
- 铁缺乏定义:血清铁蛋白<100 μg/L,或铁蛋白100-300 μg/L且转铁蛋白饱和度<20%或C反应蛋白>5 mg/L。
- 贫血定义:男性血红蛋白<130 g/L,女性血红蛋白<120 g/L。
- 主要终点:术后第30天存活且在家天数。
- 研究注册号:澳大利亚与新西兰临床试验注册中心ACTRN12618000185268。
临床怎么用
- 作者认为,按本研究所测试的定义,对无贫血择期心脏手术患者常规进行术前铁缺乏检查可能为低价值医疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: One in two adults undergoing cardiac surgery are iron deficient, best practice guidelines and consensus statements recommend routine investigation and treatment of iron deficiency before elective cardiac surgery, even in the absence of anaemia; however, it is not clear if non-anaemic iron deficiency is associated with worse outcomes in this patient population. We hypothesised that iron deficiency would be associated with worse postoperative outcomes than an iron replete state in adults without anaemia undergoing elective cardiac surgery. METHODS: We performed a prospective, cohort study at two hospitals in Australia. We recruited adults (ie, people 18 years and older) undergoing elective cardiac surgery without anaemia (defined as a haemoglobin of less than 130 g/L for men and less than 120 g/L for women), concomitant haemoglobinopathy, bone marrow pathology, haemochromatosis, or end-stage renal failure requiring dialysis. Participants were stratified as iron deficient or iron replete on the basis of preoperative testing. Iron deficiency was defined as a serum ferritin of less than 100 μg/L or 100-300 μg/L if transferrin saturation was less than 20% or C-reactive protein was more than 5 mg/L. The primary endpoint was days alive and at home at postoperative day 30. The primary analysis included all patients with data available for the primary endpoint and was adjusted for risk measured using EuroSCORE-II and body surface area. The study was prospectively registered with the Australian and New Zealand Clinical Trials Registry, ACTRN12618000185268. FINDINGS: We conducted the study between Feb 21, 2018, and May 7, 2021. We assessed 1171 patients for eligibility and 691 were ineligible; therefore, we enrolled and followed up 480 participants. 240 (50%) were iron deficient and 240 (50%) were iron replete, 95 (20%) were women, 385 (80%) were men, and 453 (94%) were White. Complete data was available for 479 individuals (240 in the iron deficient group and 239 in the iron replete group) for the primary endpoint. The iron deficient group had a median of 22·87 days (IQR 20·65 to 24·06) alive and at home at postoperative day 30, and the iron replete group had a median of 23·18 days (IQR 20·69 to 24·70). The unadjusted difference in medians between the groups was -0·18 days (95% CI -0·73 to 0·36; p=0·51) and the adjusted difference in medians between the groups was -0·11 days (95% CI -0·66 to 0·45; p=0·70). INTERPRETATION: In non-anaemic adults undergoing elective cardiac surgery, our findings suggest that patients with iron deficiency do not have a reduction in days alive and at home at postoperative day 30 compared with patients who have a normal iron status. Routine preoperative investigation for iron deficiency in patients without anaemia undergoing elective cardiac surgery using the definitions we tested might be low-value care. FUNDING: Australian and New Zealand College of Anaesthetists Foundation.
引用
- Miles LF, Pac Soo V, Braat S, et al. Associations between non-anaemic iron deficiency and outcomes following elective cardiac surgery (IDOCS): a prospective cohort study. Lancet Haematol. 2022. PMID: 35772430. doi:10.1016/S2352-3026(22)00142-9
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。